Highly specific quantification of ergotamine in urine, blood, and hair samples by liquid chromatography-tandem mass spectrometry.

Abstract

Ergotamine has been used for therapeutic purposes since the 1950s, usually to treat vascular headache. It is highly toxic and in large, repeated doses can produce all the symptoms of ergot poisoning. A selective and sensitive method, based on liquid chromatography-tandem mass spectrometry (LC-MS2), has been developed for quantifying ergotamine in biological fluids with use of a quick and easy sample preparation. Ergotamine and the internal standard, trideuterated lysergic acid diethylamide, were extracted from human urine, blood, and hair by means of liquid-liquid extraction at alkaline pH. Gradient elution on a cyanopropyl column was used for chromatographic separation. Positive ion electrospray ionization and tandem mass spectrometry determination by collision-induced dissociation were performed in an ion trap mass spectrometer. The method was validated and successfully applied to a case of iatrogenic ergotism resulting from the intake of ergotamine tartrate for treating headache. For the first time, ergotamine was identified and quantified in hair. The ergotamine concentrations measured were 320 pg/mL in blood, 100 pg/mL in urine, 24 pg/mg in proximal hair, and 15 pg/mg in distal hair.

• Authors: Donata Favretto, Giampietro Frison, Susanna Vogliardi, Santo Davide Ferrara
• Journal: Therapeutic drug monitoring (Ther Drug Monit) Vol. 29 Issue 3 Pg. 325-32 (Jun 2007) ISSN: 0163-4356 [Print] United States
• PMID: 17529890 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Vasoconstrictor Agents
• Ergotamine

Topics

• Adult
• Chromatography, High Pressure Liquid
• Chromatography, Liquid
• Ergotamine (adverse effects, blood, urine)
• Ergotism (etiology, physiopathology)
• Female
• Hair (chemistry)
• Humans
• Tandem Mass Spectrometry
• Vasoconstrictor Agents (adverse effects, blood, urine)